International Journal of Molecular Sciences · 2024 · 11 citations · 67 references
Life SciencesGeneticsMolecular BiologyCytoskeletonGene ExpressionNeuromuscular DisordersMicrorna BiologyMicrorna-mediated RegulationMuscle DisordersMuscle PhysiologyMuscular DystrophyRna InterferenceDystrophin DeficiencyDystrophin-associated Cytoskeletal DefectsMicrorna Dysregulation In DiseaseMicrorna-mediated Translational RepressionMuscular Dystrophy GeneticsMuscular Dystrophy PathophysiologySkeletal Muscle WastingTranslational Repression By Micrornas
Duchenne muscular dystrophy (DMD) is an X-linked progressive disorder associated with muscle wasting and degeneration. The disease is caused by mutations in the gene that encodes dystrophin, a protein that links the cytoskeleton with cell membrane proteins. The current treatment methods aim to relieve the symptoms of the disease or partially rescue muscle functionality. However, they are insufficient to suppress disease progression. In recent years, studies have uncovered an important role for non-coding RNAs (ncRNAs) in regulating the progression of numerous diseases. ncRNAs, such as micro-RNAs (miRNAs), bind to their target messenger RNAs (mRNAs) to suppress translation. Understanding the mechanisms involving dysregulated miRNAs can improve diagnosis and suggest novel treatment methods for patients with DMD. This review presents the available evidence on the role of altered expression of miRNAs in the pathogenesis of DMD. We discuss the involvement of these molecules in the processes associated with muscle physiology and DMD-associated cardiomyopathy.
67
Dystrophin: The protein product of the duchenne muscular dystrophy locus
Eric P. Hoffman, Robert H. Brown, Louis M. Kunkel · Cell · 1987 · 4.7K citations
The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy
Hansell H. Stedman, H. Lee Sweeney, Joseph B. Shrager et al. · Nature · 1991 · 916 citations
Medicine, Cell Biology, Neurology +12